This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio® Partnering Forum
Kerry Hotel Pudong
September 10–11, 2024 | Shanghai, ChinaSeptember 16–17, 2024 | Virtual

Min Wu
CBO at SciClone Pharmaceuticals
Speaker

Profile

Dr. Min Wu currently serves as Chief Business Development Officer at SciClone Pharmaceuticals. Dr. Wu has more than 20 years of experience in the biotech and pharmaceutical industry. Prior to joining SciClone Group, she served as CBO at Therorna, Managing Director of Fosun Health Fund and as executive director at the Asia Pacific Innovation Hub of MSD. Dr. Wu also took various leadership roles in BD functions at Amgen Asia R&D Center and Roche including Partnering, Alliance and Portfolio Management.

Dr. Wu received her Ph.D. in computational biology and chemistry from New York University. She conducted post-doctoral research at Pfizer and subsequently worked as Principal Scientist at GlaxoSmithKline. She obtained her MBA from University of Manchester, UK.

Agenda Sessions

  • CEO Perspective: China’s current and future strategies for pipeline innovation, expansion and enduring international partnerships

    11:00

At this event